Biologic scaffold for CNS repair

Regenerative Medicine

Volumn 9, Issue 3, 2014, Pages 367-383

  Meng, Fanwei ^a,b   Modo, Michel ^a,c   Badylak, Stephen F ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d University of Pittsburgh   (United States)

Author keywords

Biologic scaffold; CNS; Constructive remodeling; Decellularization; ECM; Regeneration

Indexed keywords

BIOMATERIAL; COLLAGEN; FIBRONECTIN; HYALURONIC ACID; LAMININ; TISSUE SCAFFOLD;

ACELLULAR DERMAL MATRIX; CENTRAL NERVOUS SYSTEM; DURA MATER; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; NERVE GRAFT; NERVE RECONSTRUCTION; NERVE REGENERATION; NERVOUS SYSTEM INJURY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; TISSUE REPAIR; TRAUMATIC BRAIN INJURY; CHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE; TISSUE SCAFFOLD; TRENDS;

CENTRAL NERVOUS SYSTEM; DURA MATER; EXTRACELLULAR MATRIX; HUMANS; NERVE REGENERATION; REGENERATIVE MEDICINE; TISSUE SCAFFOLDS;

EID: 84902593222     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.14.9     Document Type: Review

References (179)

1. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet 359(9304), 417-425 (2002). (Pubitemid 34158956)
2. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil. 14(6), 602-615 (1999). (Pubitemid 30027268)
3. Noble J, Munro CA, Prasad VS, Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J. Trauma 45(1), 116-122 (1998). (Pubitemid 28335168)
4. Volpato FZ, Führmann T, Migliaresi C, Hutmacher DW, Dalton PD. Using extracellular matrix for regenerative medicine in the spinal cord. Biomaterials 34(21), 4945-4955 (2013).
5. Yamaguchi Y. Lecticans: Organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 57(2), 276-289 (2000).
6. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J. Neurotrauma 23(3-4), 263-280 (2006).
7. Brook GA, Plate D, Franzen R et al. Spontaneous longitudinally orientated axonal regeneration is associated with the Schwann cell framework within the lesion site following spinal cord compression injury of the rat. J. Neurosci. Res. 53(1), 51-65 (1998).
8. Beattie MS, Bresnahan JC, Komon J et al. Endogenous repair after spinal cord contusion injuries in the rat. Exp. Neurol. 148(2), 453-463 (1997).
9. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 7(8), 617-627 (2006).
10. David S, Aguayo A. Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rats. Science 214(4523), 931-933 (1981).
11. Grandpre T, Li S, Strittmatter S. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417(6888), 547-551 (2002). (Pubitemid 34595921)
12. Shechter R, Miller O, Yovel G et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38(3), 555-569 (2013).
13. Shechter R, Raposo C, London A, Sagi I, Schwartz M. The glial scar-monocyte interplay: A pivotal resolution phase in spinal cord repair. PLoS ONE 6(12), e27969 (2011).
14. Shechter R, London A, Varol C et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6(7), e1000113 (2009).
15. Van Amerongen MJ, Harmsen MC, Van Rooijen N, Petersen AH, Van Luyn MJA. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 170(3), 818-829 (2007).
16. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-To-macrophage differentiation and polarization: New molecules and patterns of gene expression. J. Immunol. 177(10), 7303-7311 (2006). (Pubitemid 44715100)
17. Karimi-Abdolrezaee S, Schut D, Wang J, Fehlings MG. Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS ONE 7(5), e37589 (2012).
18. Mothe AJ, Tator CH. Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience 131(1), 177-187 (2005).
19. Ke Y, Chi L, Xu R, Luo C, Gozal D, Liu R. Early response of endogenous adult neural progenitor cells to acute spinal cord injury in mice. Stem Cells 24(4), 1011-1019 (2006). (Pubitemid 44464734)
20. Li S, Strittmatter SM. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23(10), 4219-4227 (2003). (Pubitemid 36958442)
21. Bradbury EJ. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416(6881), 636-640 (2002).
22. Garcia-Alias G, Lin R, Akrimi SF, Story D, Bradbury EJ, Fawcett JW. Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp. Neurol. 210(2), 331-338 (2008).
23. Stichel CC, Hermanns S, Luhmann HJ et al. Inhibition of collagen IV deposition promotes regeneration of injured CNS axons. Eur. J. Neurosci. 11(2), 632-646 (1999).
24. Kawano H, Li H-P, Sango K, Kawamura K, Raisman G. Inhibition of collagen synthesis overrides the age-related failure of regeneration of nigrostriatal dopaminergic axons. J. Neurosci. Res. 80(2), 191-202 (2005).
25. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25(11), 1418-1435 (1994). (Pubitemid 24325066)
26. Markus A, Patel TD, Snider WD. Neurotrophic factors and axonal growth. Curr. Opin. Neurobiol. 12(5), 523-531 (2002).
27. Ruff CA, Wilcox JT, Fehlings MG. Cell-based transplantation strategies to promote plasticity following spinal cord injury. Exp. Neurol. 235(1), 78-90 (2011).
28. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S et al. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28(8), 1611-1682 (2011).
29. Prang P, Müller R, Eljaouhari A et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials 27(19), 3560-3569 (2006).
30. Stokols S, Tuszynski MH. The fabrication and characterization of linearly oriented nerve guidance scaffolds for spinal cord injury. Biomaterials 25(27), 5839-5846 (2004). (Pubitemid 38681168)
31. Teng YD, Lavik EB, Qu X et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl Acad. Sci. USA 99(5), 3024-3029 (2002).
32. Oudega M, Gautier SE, Chapon P et al. Axonal regeneration into Schwann cell grafts within resorbable poly(α-hydroxyacid) guidance channels in the adult rat spinal cord. Biomaterials 22(10), 1125-1136 (2001). (Pubitemid 32229937)
33. Willerth SM, Sakiyama-Elbert SE. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Deliv. Rev. 59(4-5), 325-338 (2007).
34. Ye J-H, Houle JD. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp. Neurol. 143(1), 70-81 (1997).
35. Deng L-X, Deng P, Ruan Y et al. A novel growth-promoting pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal regeneration, synapse formation, and partial recovery of function after spinal cord injury. J. Neurosci. 33(13), 5655-5667 (2013).
36. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin. Cell Dev. Biol. 13(5), 377-383 (2002).
37. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials 28(25), 3587-3593 (2007). (Pubitemid 46855878)
38. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 27(19), 3675-3683 (2006).
39. Badylak SF, Vorp DA, Spievack AR et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J. Surg. Res. 128(1), 87-97 (2005).
40. Wolf MT, Daly KA, Reing JE, Badylak SF. Biologic scaffold composed of skeletal muscle extracellular matrix. Biomaterials 33(10), 2916-2925 (2013).
41. Valentin JE, Turner NJ, Gilbert TW, Badylak SF. Functional skeletal muscle formation with a biologic scaffold. Biomaterials 31(29), 7475-7484 (2010).
42. DeQuach J, Yuan S, Goldstein L, Christman K. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng. Part A 17(21-22), 2583-2592 (2011).
43. Wang J, Liou A, Ren Z et al. Neurorestorative effect of urinary bladder matrix-mediated neural stem cell transplantation following traumatic brain injury in rats. CNS Neurol. Disord. Drug Targets 12(3), 413-425 (2013).
44. Medberry CJ, Crapo PM, SIU Bf et al. Hydrogels derived from central nervous system extracellular matrix. Biomaterials 34(4), 1033-1040 (2012).
45. Crapo PM, Medberry CJ, Reing JE et al. Biologic scaffolds composed of central nervous system extracellular matrix. Biomaterials 33(13), 3539-3547 (2012).
46. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 32(12), 3233-3243 (2011).
47. Bissell M, Barcellos-Hoff M. The influence of extracellular matrix on gene expression: Is structure the message? J. Cell. Sci. Suppl. 8, 327-343 (1987).
48. Berthiaume F, Moghe PV, Toner M, Yarmush ML. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: Hepatocytes cultured in a sandwich configuration. FASEB J. 10(13), 1471-1484 (1996). (Pubitemid 26384444)
49. Petersen OW, Rønnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl Acad. Sci. USA 89(19), 9064-9068 (1992).
50. Tanaka H, Murphy CL, Murphy C, Kimura M, Kawai S, Polak JM. Chondrogenic differentiation of murine embryonic stem cells: Effects of culture conditions and dexamethasone. J. Cell. Biochem. 93(3), 454-462 (2004).
51. Calve S, Odelberg SJ, Simon H-G. A transitional extracellular matrix instructs cell behavior during muscle regeneration. Dev. Biol. 344(1), 259-271 (2010).
52. McClelland R, Wauthier E, Uronis J, Reid L. Gradients in the liver's extracellular matrix chemistry from periportal to pericentral zones: Influence on human hepatic progenitors. Tissue Eng. Part A 14(1), 59-70 (2008). (Pubitemid 351520435)
53. Bosman FT, Stamenkovic I. Functional structure and composition of the extracellular matrix. J. Pathol. 200(4), 423-428 (2003). (Pubitemid 36818243)
54. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 11(1), 51-59 (1997). (Pubitemid 27076324)
55. Zantop T, Gilbert TW, Yoder MC, Badylak SF. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction. J. Orthop. Res. 24(6), 1299-1309 (2006).
56. Turner N, Yates AJ, Weber D et al. Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction. Tissue Eng. Part A 16(11), 3309-3317 (2010).
57. Valentin J, Stewart-Akers A, Gilbert T, Badylak S. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng. Part A 15(7), 1687-1694 (2009).
58. Adair-Kirk TL, Senior RM. Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 40(6-7), 1101-1110 (2008).
59. Davis GE, Bayless KJ, Davis MJ, Meininger GA. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 156(5), 1489-1498 (2000).
60. Reing J, Zhang L, Myers-Irvin J et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng. Part A 15(3), 605-614 (2009).
61. Homandberg G, Williams J, Grant D, Schumacher B, Eisenstein R. Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am. J. Pathol. 120(3), 327-332 (1985).
62. Agrawal V, Tottey S, Johnson S, Freund J, Siu B, Badylak S. Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation. Tissue Eng. Part A 17(19-20), 2435-2443 (2011).
63. Ge M, Ryan TJ, Lum H, Malik AB. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 261(4), L283-L289 (1991).
64. Rowland F, Donovan M, Picciano P, Wilner G, Kreutzer D. Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction. Am. J. Pathol. 117(3), 418-428 (1984).
65. Sage E. Pieces of eight: Bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol. 7(5), 182-186 (1997). (Pubitemid 27354781)
66. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30(8), 1482-1491 (2009).
67. Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 141(2), 539-551 (1998). (Pubitemid 28237100)
68. Ingham KC, Brew SA, Migliorini M. Type I collagen contains at least 14 cryptic fibronectin binding sites of similar affinity. Arch. Biochem. Biophys. 407(2), 217-223 (2002).
69. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. Identification of extractable growth factors from small intestinal submucosa. J. Cell. Biochem. 67(4), 478-491 (1997).
70. Hodde J, Record R, Liang H, Badylak S. Vascular endothelial growth factor in porcine-derived extracellular matrix. Endothelium 8(1), 11-24 (2001). (Pubitemid 32454574)
71. McDevitt CA, Wildey GM, Cutrone RM. Transforming growth factor-β1 in a sterilized tissue derived from the pig small intestine submucosa. J. Biomed. Mater. Res. Part A 67A(2), 637-640 (2003).
72. Hodde J, Hiles M. Bioactive FGF-2 in sterilized extracellular matrix. Wounds 13, 195 (2001).
73. Hodde J, Ernst D, Hiles M. An investigation of the long-Term bioactivity of endogenous growth factor in Oasis wound matrix. J. Wound Care 14(1), 23-25 (2005).
74. Brown BN, Londono R, Tottey S et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater. 8(3), 978-987 (2012).
75. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A 14(11), 1835-1842 (2008).
76. Mosser D, Edwards J. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8(12), 958-969 (2008).
77. Dandy WE. Treatment of rhinorrhea and otorrhea. Arch. Surg. 49(2), 75-85 (1944).
78. Cushing H. A study of a series of wounds involving the brain and its enveloping structures. Br. J. Surg. 5(20), 558-684 (1917).
79. Hoshi K, Yoshino H, Urata J, Nakamura Y, Yanagawa H, Sato T. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 55(5), 718-721 (2000).
80. Haywood AM. Transmissible spongiform encephalopathies. N. Engl. J. Med. 337(25), 1821-1828 (1997).
81. Kline DG. Dural replacement with resorbable collagen. Arch. Surg. 91(6), 924-929 (1965).
82. Jannetta P, Whayne TJ. Formaldehyde-Treated, regenerated collagen film and film-laminate as a substitute for dura mater. Surg. Forum 16, 435-437 (1965).
83. Lee JF, Odom GL, Tindall GT. Experimental evaluation of silicone-coated dacron and collagen fabric-film laminate as dural substitutes. J. Neurosurg. 27(6), 558-564 (1967).
84. Laquerriere A, Yun J, Tiollier JR, Hemet J, Tadie M. Experimental evaluation of bilayered human collagen as a dural substitute. J. Neurosurg. 78(3), 487-491 (1993). (Pubitemid 23073222)
85. Narotam P, Van Dellen J, Bhoola K, Raidoo D. Experimental evaluation of collagen sponge as a dural graft. Br. J. Neurosurg. 7(6), 635-641 (1993).
86. Narotam PK, Van Dellen JR, Bhoola KD. A clinicopathological study of collagen sponge as a dural graft in neurosurgery. J. Neurosurg. 82(3), 406-412 (1995).
87. Zerris VA, James KS, Roberts JB, Bell E, Heilman CB. Repair of the dura mater with processed collagen devices. J. Biomed. Mater. Res. B Appl. Biomater. 83B(2), 580-588 (2007).
88. Barbolt TA, Odin M, Léger M, Kangas L, Holste J, Liu SH. Biocompatibility evaluation of dura mater substitutes in an animal model. Neurol. Res. 23(8), 813-820 (2001).
89. Knopp U, Christmann F, Reusche E, Sepehrnia A. A new collagen biomatrix of equine origin versus a cadaveric dura graft for the repair of dural defects-A comparative animal experimental study. Acta Neurochir. 147(8), 877-887 (2005). (Pubitemid 41103969)
90. Gazzeri R, Neroni M, Alfieri A et al. Transparent equine collagen biomatrix as dural repair. A prospective clinical study. Acta Neurochir. 151(5), 537-543 (2009).
91. Parlato C, Nuzzo G, Luongo M et al. Use of a collagen biomatrix (TissuDura) for dura repair: A long-Term neuroradiological and neuropathological evaluation. Acta Neurochir. 153(1), 142-147 (2011).
92. Chaplin J, Costantino P, Wolpoe M, Bederson J, Griffey E, Zhang W. Use of an acellular dermal allograft for dural replacement: An experimental study. Neurosurgery 45(2), 320-327 (1999). (Pubitemid 29395109)
93. Warren W, Medary M, Dureza C et al. Dural repair using acellular human dermis: Experience with 200 cases: Technique assessment. Neurosurgery 46(6), 1391-1396 (2000). (Pubitemid 32037671)
94. Islam S, Ogane K, Ohkuma H, Suzuki S. Usefulness of acellular dermal graft as a dural substitute in experimental model. Surg. Neurol. 61(3), 297-302 (2004).
95. Cobb MA, Badylak SF, Janas W, Boop FA. Histology after dural grafting with small intestinal submucosa. Surg. Neurol. 46(4), 389-393 (1996).
96. Cobb MA, Badylak SF, Janas W, Simmons-Byrd A, Boop FA. Porcine small intestinal submucosa as a dural substitute. Surg. Neurol. 51(1), 99-104 (1999).
97. Zin ZK, Brian DM, Jennifer EV, Stephanie KS, Raymond JG, Christine ES. High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury. J. Neural. Eng. 8(4), 046033 (2011).
98. Lin C-M, Lin J-W, Chen Y-C et al. Hyaluronic acid inhibits the glial scar formation after brain damage with tissue loss in rats. Surg. Neurol. 72, S50-S54 (2009).
99. Cui FZ, Tian WM, Hou SP, Xu QY, Lee IS. Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering. J. Mater. Sci. Mater. Med. 17(12), 1393-1401 (2006).
100. Horn EM, Beaumont M, Shu XZ et al. Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth and recovery from spinal cord injury. J. Neurosurg. Spine 6(2), 133-140 (2007). (Pubitemid 47066056)
101. Wei YT, Tian WM, Yu X et al. Hyaluronic acid hydrogels with IKVAV peptides for tissue repair and axonal regeneration in an injured rat brain. Biomed. Mater. 2(3), S142 (2007).
102. Hou S, Xu Q, Tian W et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J. Neurosci. Methods 148(1), 60-70 (2005). (Pubitemid 41423459)
103. King VR, Alovskaya A, Wei DYT, Brown RA, Priestley JV. The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury. Biomaterials 31(15), 4447-4456 (2010).
104. King VR, Hewazy D, Alovskaya A, Phillips JB, Brown RA, Priestley JV. The neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat. Neuroscience 168(2), 523-530 (2010).
105. King VR, Phillips JB, Hunt-Grubbe H, Brown R, Priestley JV. Characterization of non-neuronal elements within fibronectin mats implanted into the damaged adult rat spinal cord. Biomaterials 27(3), 485-496 (2006). (Pubitemid 41457251)
106. King VR, Henseler M, Brown RA, Priestley JV. Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Exp. Neurol. 182(2), 383-398 (2003).
107. Phillips JB, King VR, Ward Z, Porter RA, Priestley JV, Brown RA. Fluid shear in viscous fibronectin gels allows aggregation of fibrous materials for CNS tissue engineering. Biomaterials 25(14), 2769-2779 (2004). (Pubitemid 38201302)
108. Spilker MH, Yannas IV, Kostyk SK, Norregaard TV, Hsu HP, Spector M. The effects of tubulation on healing and scar formation after transection of the adult rat spinal cord. Restor. Neurol. Neurosci. 18(1), 23-38 (2001).
109. Liu S, Peulve P, Jin O et al. Axonal regrowth through collagen tubes bridging the spinal cord to nerve roots. J. Neurosci. Res. 49(4), 425-432 (1997).
110. Liu S, Said G, Tadie M. Regrowth of the rostral spinal axons into the caudal ventral roots through a collagen tube implanted into hemisected adult rat spinal cord. Neurosurgery 49(1), 143-150 (2001).
111. Liu S, Bodjarian N, Langlois O et al. Axonal regrowth through a collagen guidance channel bridging spinal cord to the avulsed C6 roots: Functional recovery in primates with brachial plexus injury. J. Neurosci. Res. 51(6), 723-734 (1998).
112. Liu T, Houle J, Xu J, Chan B, Chew S. Nanofibrous collagen nerve conduits for spinal cord repair. Tissue Eng. Part A 18(9-10), 1057-1066 (2012).
113. Yoshii S, Oka M, Shima M, Akagi M, Taniguchi A. Bridging a spinal cord defect using collagen filament. Spine 28(20), 2346-2351 (2003). (Pubitemid 37271330)
114. Yoshii S, Ito S, Shima M, Taniguchi A, Akagi M. Functional restoration of rabbit spinal cord using collagen-filament scaffold. J. Tissue Eng. Regen. Med. 3(1), 19-25 (2009).
115. Fukushima K, Enomoto M, Tomizawa S et al. The axonal regeneration across a honeycomb collagen sponge applied to the transected spinal cord. J. Med. Dent. Sci. 55(1), 71-79 (2008).
116. Joosten E, Bär P, Gispen W. Collagen implants and cortico-spinal axonal growth after mid-Thoracic spinal cord lesion in the adult rat. J. Neurosci. Res. 41(4), 481-490 (1995).
117. Berry M, Hall S, Follows R, Rees L, Gregson N, Sievers J. Response of axons and glia at the site of anastomosis between the optic nerve and cellular or acellular sciatic nerve grafts. J. Neurocytol. 17(6), 727-744 (1988). (Pubitemid 19020211)
118. Berry M, Rees L, Hall S, Yiu P, Sievers J. Optic axons regenerate into sciatic nerve isografts only in the presence of Schwann cells. Brain Res. Bull. 20(2), 223-231 (1988).
119. Hall S, Berry M. Electron microscopic study of the interaction of axons and glia at the site of anastomosis between the optic nerve and cellular or acellular sciatic nerve grafts. J. Neurocytol. 18(2), 171-184 (1989). (Pubitemid 19111954)
120. Li C, Zhang X, Cao R et al. Allografts of the acellular sciatic nerve and brain-derived neurotrophic factor repair spinal cord injury in adult rats. PLoS ONE 7(8), e42813 (2012).
121. Guo S-Z, Ren X-J, Wu B, Jiang T. Preparation of the acellular scaffold of the spinal cord and the study of biocompatibility. Spinal Cord 48(7), 576-581 (2010).
122. Jiang T, Ren X, Tang J, Yin H, Wang K, Zhou C. Preparation and characterization of genipin-crosslinked rat acellular spinal cord scaffolds. Mater. Sci. Eng. C Mater. Biol. Appl. 33(6), 3514-3521 (2013).
123. Liu J, Chen J, Liu B et al. Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats. J. Neurol. Sci. 325(1-2), 127-136 (2013).
124. Zhang X-Y, Xue H, Liu J-M, Chen D. Chemically extracted acellular muscle: A new potential scaffold for spinal cord injury repair. J. Biomed. Mater. Res. Part A 100A(3), 578-587 (2012).
125. Zhang L, Zhang F, Weng Z et al. Effect of an inductive hydrogel composed of urinary bladder matrix upon functional recovery following traumatic brain injury. Tissue Eng. Part A 19(17-18), 1909-1918 (2013).
126. Bible E, Dell'Acqua F, Solanky B et al. Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by 19F-And diffusion-MRI. Biomaterials 33(10), 2858-2871 (2012).
127. Costa C, Tortosa R, Domã Nech A, Vidal E, Pumarola M, Bassols A. Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse. J. Chem. Neuroanat. 33(3), 111-123 (2007).
128. Manuskiatti W, Maibach H. Hyaluronic acid and skin: Wound healing and aging. Int. J. Dermatol. 35(8), 539-544 (1996).
129. Seidlits SK, Khaing ZZ, Petersen RR et al. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation. Biomaterials 31(14), 3930-3940 (2010).
130. Neumann A, Schinzel R, Palm D, Riederer P, Münch G. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett. 453(3), 283-287 (1999). (Pubitemid 29326664)
131. Austin JW, Gilchrist C, Fehlings MG. High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation. J. Neurochem. 122(2), 344-355 (2012).
132. Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A. Molecular size hyaluronan differently modulates Toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie 92(2), 204-215 (2010).
133. Tian W, Hou S, Ma J et al. Hyaluronic acid-poly-d-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Eng. 11(3-4), 513-525 (2005). (Pubitemid 40632567)
134. Hou S, Tian W, Xu Q et al. The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro. Neuroscience 137(2), 519-529 (2006). (Pubitemid 43031517)
135. Abaskharoun M, Bellemare M, Lau E, Margolis RU. Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells. Brain Res. 1327(0), 6-15 (2010).
136. Preston M, Sherman L. Neural stem cell niches: Roles for the hyaluronan-based extracellular matrix. Front Biosci. (Schol. Ed.) 3, 1165-1179 (2011).
137. Pan L, Ren Y, Cui F, Xu Q. Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold. J. Neurosci. Res. 87(14), 3207-3220 (2009).
138. Zhang T, Yan Y, Wang X et al. Three-dimensional gelatin and gelatin/hyaluronan hydrogel structures for traumatic brain injury. J. Bioact. Compat. Polym. 22(1), 19-29 (2007).
139. Rampon C, Weiss N, Deboux C et al. Molecular mechanism of systemic delivery of neural precursor cells to the brain: Assembly of brain endothelial apical cups and control of transmigration by CD44. Stem Cells 26(7), 1673-1682 (2008).
140. Cooke MJ, Wang Y, Morshead CM, Shoichet MS. Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. Biomaterials 32(24), 5688-5697 (2011).
141. Meng F, Hlady V, Tresco PA. Inducing alignment in astrocyte tissue constructs by surface ligands patterned on biomaterials. Biomaterials 33(5), 1323-1335 (2012).
142. Ingham KC, Brew SA, Huff S, Litvinovich SV. Cryptic self-Association sites in Type III modules of fibronectin. J. Biol. Chem. 272(3), 1718-1724 (1997).
143. Martin DE, Reece MC, Maher JE, Reese AC. Tissue debris at the injury site is coated by plasma fibronectin and subsequently removed by tissue macrophages. Arch. Dermatol. 124(2), 226-229 (1988).
144. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98(5), 1567-1576 (2001).
145. Proctor R. Fibronectin: An enhancer of phagocyte function. Rev. Infect. Dis. 9(Suppl. 4), S412-S419 (1987).
146. Fukai F, Mashimo M, Akiyama K, Goto T, Tanuma S-I, Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp. Cell Res. 242(1), 92-99 (1998).
147. Sakai T, Johnson KJ, Murozono M et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat. Med. 7, 324-330 (2001).
148. Yanaka K, Camarata PJ, Spellman SR et al. Synthetic fibronectin peptides and ischemic brain injury after transient middle cerebral artery occlusion in rats. J. Neurosurg. 85(1), 125-130 (1996). (Pubitemid 26195047)
149. Zhao LR, Spellman S, Kim J, Duan W-M, Mccarthy JB, Low WC. Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats. Brain Res. 1054(1), 1-8 (2005). (Pubitemid 41188123)
150. Tate CC, Shear DA, Tate MC, Archer DR, Stein DG, Laplaca MC. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J. Tissue Eng. Regen. Med. 3(3), 208-217 (2009).
151. Thompson D, Buettner H. Neurite outgrowth is directed by Schwann cell alignment in the absence of other guidance cues. Ann. Biomed. Eng. 34(1), 161-168 (2006).
152. Elias P, Spector M. Characterization of a bilateral penetrating brain injury in rats and evaluation of a collagen biomaterial for potential treatment. J. Neurotrauma 29(11), 2086-2102 (2012).
153. Liu T, Teng WK, Chan BP, Chew SY. Photochemical crosslinked electrospun collagen nanofibers: Synthesis, characterization and neural stem cell interactions. J. Biomed. Mater. Res. Part A 95A(1), 276-282 (2010).
154. Lanfer B, Hermann A, Kirsch M et al. Directed growth of adult human white matter stem cell-derived neurons on aligned fibrillar collagen. Tissue Eng. Part A 16(4), 1103-1113 (2010).
155. Wang Y, Yao M, Zhou J et al. The promotion of neural progenitor cells proliferation by aligned and randomly oriented collagen nanofibers through β1 integrin/MAPK signaling pathway. Biomaterials 32(28), 6737-6744 (2011).
156. Möllers S, Hesche Li, Damink L et al. Cytocompatibility of a novel, longitudinally microstructured collagen scaffold intended for nerve tissue repair. Tissue Eng. Part A 15(3), 461-472 (2009).
157. Marchand R, Woerly S. Transected spinal cords grafted with in situ self-Assembled collagen matrices. Neuroscience 36(1), 45-60 (1990). (Pubitemid 20221714)
158. Watanabe K, Nakamura M, Okano H, Toyama Y. Establishment of three-dimensional culture of neural stem/progenitor cells in collagen type-1 gel. Restor. Neurol. Neurosci. 25(2), 109-117 (2007).
159. Ma W, Fitzgerald W, Liu Qy et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp. Neurol. 190(2), 276-288 (2004).
160. O'Connor SM, Stenger DA, Shaffer KM, Ma W. Survival and neurite outgrowth of rat cortical neurons in three-dimensional agarose and collagen gel matrices. Neurosci. Lett. 304(3), 189-193 (2001).
161. Jennie BL, Xin QB, Jeffrey GJ, Paul AD, Joyce YW. Neurite outgrowth and branching of PC12 cells on very soft substrates sharply decreases below a threshold of substrate rigidity. J. Neural. Eng. 4(2), 26 (2007).
162. Elias PZ, Spector M. Viscoelastic characterization of rat cerebral cortex and type I collagen scaffolds for central nervous system tissue engineering. J. Mech. Behav. Biomed. Mater. 12(0), 63-73 (2012).
163. Macaya D, Ng KK, Spector M. Injectable collagen-genipin gel for the treatment of spinal cord injury: In vitro studies. Adv. Func. Mater. 21(24), 4788-4797 (2011).
164. Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and their receptors: Functions in neural development. Annu. Rev. Neurosci. 14(1), 531-570 (1991).
165. Perris R, Perissinotto D. Role of the extracellular matrix during neural crest cell migration. Mech. Dev. 95(1-2), 3-21 (2000).
166. Chen Z-L, Indyk JA, Strickland S. The hippocampal laminin matrix is dynamic and critical for neuronal survival. Mol. Biol. Cell 14(7), 2665-2676 (2003).
167. Tate C, Tate M, Laplaca M. Fibronectin and laminin increase in the mouse brain after controlled cortical impact injury. J. Neurotrauma 24(1), 226-230 (2007). (Pubitemid 46214428)
168. Hausmann R, Betz P. The time course of the vascular response to human brain injury-An immunohistochemical study. Int. J. Legal. Med. 113(5), 288-292 (2000).
169. Tate MC, Garcia AJ, Keselowsky BG, Schumm MA, Archer DR, Laplaca MC. Specific beta1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol. Cell. Neurosci. 27(1), 22-31 (2004).
170. Leone DP, Relvas JOB, Campos LS et al. Regulation of neural progenitor proliferation and survival by β1 integrins. J. Cell. Sci. 118(12), 2589-2599 (2005).
171. Nakaji-Hirabayashi T, Kato K, Iwata H. Improvement of neural stem cell survival in collagen hydrogels by incorporating laminin-derived cell adhesive polypeptides. Bioconjug. Chem. 23(2), 212-221 (2012).
172. Hiraoka M, Kato K, Nakaji-Hirabayashi T, Iwata H. Enhanced survival of neural cells embedded in hydrogels composed of collagen and laminin-derived cell adhesive peptide. Bioconjug. Chem. 20(5), 976-983 (2009).
173. Jurga M, Dainiak MB, Sarnowska A et al. The performance of laminin-containing cryogel scaffolds in neural tissue regeneration. Biomaterials 32(13), 3423-3434 (2011).
174. Yao L, Damodaran G, Nikolskaya N, Gorman AM, Windebank A, Pandit A. The effect of laminin peptide gradient in enzymatically cross-linked collagen scaffolds on neurite growth. J. Biomed. Mater. Res. Part A 92A(2), 484-492 (2010).
175. Milner R, Crocker SJ, Hung S, Wang X, Frausto RF, Del Zoppo GJ. Fibronectin-And vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins a5b1 and avb5. J. Immunol. 178(12), 8158-8167 (2007).
176. Xue H, Zhang X-Y, Liu J-M, Song Y, Li Y-F, Chen D. Development of a chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells to promote spinal cord repair. J. Biomed. Mater. Res. Part A 101A(1), 145-156 (2012).
177. Agrawal V, Brown BN, Beattie AJ, Gilbert TW, Badylak SF. Evidence of innervation following extracellular matrix scaffold-mediated remodelling of muscular tissues. J. Tissue Eng. Regen. Med. 3(8), 590-600 (2009).
178. Crapo PM, Tottey S, Sliva PF, Badylak SF. Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering. Tissue Eng. Part A 20(1-2), 313-323 (2014))
179. Tottey S, Johnson SA, Crapo PM et al. The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials 32(1), 128-136 (2011).